Whereas, no differences in the plasma levels of eotaxin-1/CCL11 and eotaxin-3/CCL26 were detected between the two groups (Figure 3E,G), circulating levels of eotaxin-2/CCL24 were significantly lower in the metabolic syndrome group than in the controls (Figure 3F). This evidence concerns the gene CCL26 and metabolic syndrome.